Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome

Summary

The goal of this study is to begin to test whether or not pioglitazone, an FDA approved medication used to treat high blood sugar, may be safe and effective in treating Major Depressive Disorder (MDD) in patients with comorbid Metabolic Syndrome (METSYN).

Timeline

Start

2008-04

Primary completion

2011-08

Completion

2011-11

Drugs

Indications